BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7515733)

  • 1. [Interferons, a class of cytokines with a large therapeutic activity range].
    Billard C
    Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of interferon therapy].
    Dittrich C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferons in hemato-cancerology].
    Boiron M
    Nouv Rev Fr Hematol (1978); 1987; 29(1):49-55. PubMed ID: 2438645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases.
    Borden EC
    Oncologist; 1998; 3(3):198-203. PubMed ID: 10388104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferons in the therapy of solid tumors].
    Tomao S; Mozzicafreddo A; Raffaele M; Romiti A; Papò MA; Campisi C
    Clin Ter; 1995; 146(8-9):491-502. PubMed ID: 8536432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Various aspects and results of therapy with interferon].
    Niederle N
    Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha interferons--new therapeutic modalities].
    Bajcetić M; Zigon N; Samardzić R; Beleslin DB
    Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in the treatment of hematological disorders: recent progress and perspectives.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):5-9. PubMed ID: 8874763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interferons.
    Itri LM
    Cancer; 1992 Aug; 70(4 Suppl):940-5. PubMed ID: 1379116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interferons in the treatment of malignant neoplasms.
    Murren JR; Buzaid AC
    Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of biological activity of interferons.
    Battistini A; Affabris E; Fiorucci G; Coccia EM; Romeo G; Marziali G; Rossi GB
    Ann Ist Super Sanita; 1990; 26(3-4):227-53. PubMed ID: 1708952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of interferons in the treatment of cancer.
    Hansen RM; Borden EC
    Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotherapy in clinical practice.
    Figlin RA
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interferons. Mechanisms of action and clinical applications.
    Baron S; Tyring SK; Fleischmann WR; Coppenhaver DH; Niesel DW; Klimpel GR; Stanton GJ; Hughes TK
    JAMA; 1991 Sep; 266(10):1375-83. PubMed ID: 1715409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25-dihydroxyvitamin D3, and analogs.
    Bollag W
    J Cell Biochem; 1994 Dec; 56(4):427-35. PubMed ID: 7890801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons.
    Matikainen S; Ronni T; Lehtonen A; Sareneva T; Melén K; Nordling S; Levy DE; Julkunen I
    Cell Growth Differ; 1997 Jun; 8(6):687-98. PubMed ID: 9186002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.